Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine and Methadone for HIV-Associated Neuropathy
NCT00863057Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of duloxetine and methadone in HIV-associated peripheral neuropathy (PN) (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Weekly Mean Pain Score Derived From Self-reported Average Daily Pain Intensity. Started May 2009; status: terminated.
02
Drugs
duloxetinemethadone
03
Conditions
HIV-associated peripheral neuropathy (PN)
Beyond the preview
Go deeper on NCT00863057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863057.